Quarterly Result4 Feb 2026, 01:28 pm
Syncom Formulations India Ltd. to Approve Q3 and Nine Months Financial Results on February 12, 2026
AI Summary
Syncom Formulations India Ltd. has announced that its Board of Directors will meet on February 12, 2026, to consider and approve the Standalone and Consolidated unaudited Financial Results for the Quarter and Nine Months ended 31 December, 2025. The meeting will also take on record the Standalone and Consolidated Limited Review Report by Auditors for the unaudited Financial Results. Additionally, the Board will consider other incidental matters.
Key Highlights
- The Board of Directors of Syncom Formulations India Ltd. will meet on February 12, 2026
- The meeting will consider and approve the Standalone and Consolidated unaudited Financial Results for the Quarter and Nine Months ended 31 December, 2025
- The Board will take on record the Standalone and Consolidated Limited Review Report by Auditors for the unaudited Financial Results
- The meeting will also consider other incidental matters
- The company is in the process of filing the Corporate Announcement in the XBRL format within the stipulated time
Price Impact
More from SYNCOMF